PIK3CA was the only common target of key constituents and candidate stroke/TRFS targets, which may play an extremely important role in the treatment of XLCQ acting on stroke complicated with TRFS and needed to be focused on in the further experiment. This evidence concerns the gene PIK3CA and Stroke.